| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/07/1997 | CA2243191A1 Diagnostic method and apparatus |
| 08/06/1997 | EP0787499A1 Kininogen for promoting bone formation and inhibiting bone resorption |
| 08/06/1997 | EP0787122A2 Calcium receptor-active compounds |
| 08/06/1997 | EP0787013A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 08/06/1997 | CN1155999A Positive molecular bone intensifying agent and its producing technology |
| 08/05/1997 | US5654334 Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester |
| 08/05/1997 | US5654173 Secreted proteins and polynucleotides encoding them |
| 07/31/1997 | WO1997027174A1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 07/31/1997 | WO1997026790A1 APOPTOSIS INDUCED BY SHIGELLA IpaB |
| 07/30/1997 | EP0786473A2 Basic protein composition, basic peptide composition and application thereof |
| 07/30/1997 | EP0785803A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 07/30/1997 | EP0785781A2 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
| 07/30/1997 | EP0785769A1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
| 07/30/1997 | CN1155430A Chinese drug for osteoporosis and the preparation thereof |
| 07/29/1997 | US5652243 Modulating cellular response |
| 07/29/1997 | US5652235 Method of using spiro piperidines to promote the release of growth hormone |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026326A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
| 07/24/1997 | WO1997026250A1 Integrin receptor antagonists |
| 07/24/1997 | WO1997025999A1 Peptides for altering osteoblast adhesion |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/24/1997 | CA2242911A1 Peptides for altering osteoblast adhesion |
| 07/24/1997 | CA2242877A1 Integrin receptor antagonists |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0784480A1 Use of erythropoietin in the treatment of rheumatoid arthritis |
| 07/23/1997 | EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/22/1997 | US5650168 Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 07/17/1997 | WO1997025315A1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
| 07/17/1997 | WO1997025077A1 SKIN-ADHERING PHARMACEUTICAL PREPARATION, IN PARTICULAR TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-β-ESTRADIOL TO THE HUMAN ORGANISM |
| 07/17/1997 | WO1997025049A1 Composition containing diosgenin |
| 07/17/1997 | WO1997025048A1 Novel cycloalkyl substituted imidazoles |
| 07/17/1997 | WO1997025047A1 Novel cycloalkyl substituded imidazoles |
| 07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025045A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025025A1 Combination injection preparation |
| 07/17/1997 | WO1997024929A1 Human g-protein coupled receptor |
| 07/17/1997 | CA2242589A1 Composition containing diosgenin |
| 07/17/1997 | CA2242364A1 Combination injection preparation |
| 07/17/1997 | CA2242327A1 Novel substituted imidazole compounds |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/15/1997 | US5648373 CoA-IT and PAF inhibitors |
| 07/10/1997 | WO1997024369A1 Growth-hormone secretagogues |
| 07/10/1997 | WO1997024133A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | WO1997024124A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024122A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024119A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024117A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 07/10/1997 | DE19600347A1 Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus Skin-adhesive pharmaceutical preparation, particularly TTS for the delivery of 17-beta-estradiol on the human organism |
| 07/10/1997 | CA2254791A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | CA2241724A1 Vitronectin receptor antagonists |
| 07/10/1997 | CA2241633A1 Vitronectin receptor antagonists |
| 07/09/1997 | EP0720602B1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
| 07/09/1997 | CN1153784A Biotin derivatives |
| 07/08/1997 | US5646137 Administering antiestrogen, i.e. raloxifene, and a progestin |
| 07/08/1997 | US5646134 Inhibiting bone resorption |
| 07/08/1997 | US5646129 Exposing mesenchymal cells to hyaluronic acid |
| 07/08/1997 | US5646116 Administering insulin-like growth factor i to a mammal |
| 07/03/1997 | WO1997023625A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023508A1 Compounds with growth hormone releasing properties |
| 07/03/1997 | WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | WO1997023480A1 Novel integrin receptor antagonists |
| 07/03/1997 | WO1997023465A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 07/03/1997 | WO1997023461A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023460A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023459A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/03/1997 | WO1997023457A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | WO1997023451A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
| 07/03/1997 | WO1997011692A3 Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 07/03/1997 | DE19548709A1 Tyrosinderivate Tyrosine derivatives |
| 07/03/1997 | CA2241688A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | CA2241149A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
| 07/03/1997 | CA2240439A1 Novel integrin receptor antagonists |
| 07/03/1997 | CA2239711A1 Compounds with growth hormone releasing properties |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/02/1997 | EP0781555A1 Benzothiophene formulations of a specific dosage |
| 07/02/1997 | EP0781277A1 Neurokinin antagonists |
| 07/01/1997 | US5643964 Natural amino acid derivatives as metalloproteinase inhibitors |
| 07/01/1997 | US5643932 Superoxide radical inhibitor |